Jill P Smith

USPTO Granted Patents = 18 (Patent Applications = 15)

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 56(Granted Patents)

Location History:

Washington, DC (US) (2022 - 2023)
Camp Hill, PA (US) (1998 - 2024)

Company Filing History:

5 out of 1,217

The Penn State Research Foundation

patents

5 out of 484

Georgetown University

patents

3 out of 8

Cancer Advances, Inc.

patents

4. 2 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

5. 1 out of 1

The Penn State University Research Foundation

patent

6. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12453735 - Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor (2025-10-28),

2. 12251364 - Treating non-alcoholic steatohepatitis with cck inhibitors (2025-03-18),

3. 12150978 - Compositions and methods for preventing tumors and cancer (2024-11-26),

4. 12076383 - Compositions and methods for inducing humoral and cellular immunities against tumors and cancer (2024-09-03),

5. 11696922 - Nanoparticle to target cancer (2023-07-11),

6. 11583576 - Compositions and methods for inducing humoral and cellular immunities against tumors and cancer (2023-02-21),

7. 11278551 - Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor (2022-03-22),

8. 11246881 - Nanoparticle to target cancer (2022-02-15),

9. 10668126 - Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor (2020-06-02),

10. 9562095 - Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibody (2017-02-07),

11. 9375458 - Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor (2016-06-28),

12. 9149544 - Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo (2015-10-06),

13. 8889640 - Composition and method for the treatment of gastrin mediated cancers (2014-11-18),

14. 8821872 - Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer (2014-09-02),

15. 8003630 - Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor (2011-08-23),

Title: The Innovative Journey of Inventor Jill P Smith

Introduction: Inventor Jill P Smith, a talented individual hailing from Camp Hill, PA (US), has made significant contributions to the world of inventions with his creative mind and dedication to innovation.

Latest Patents: Jill P Smith's latest patents showcase his expertise in various fields, including technology, healthcare, and consumer products. His recent inventions have been recognized for their ingenuity and practicality.

Career Highlights: Throughout his career, Jill P Smith has demonstrated a remarkable ability to transform ideas into tangible inventions. His passion for innovation has led to the development of groundbreaking technologies that have improved the lives of many.

Collaborations: Jill P Smith has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His partnerships have been instrumental in turning his innovative concepts into successful products that have made a positive impact on society.

Conclusion: Jill P Smith's journey as an inventor is a testament to his unwavering commitment to pushing the boundaries of what is possible through innovation. His remarkable achievements continue to inspire aspiring inventors and pave the way for future advancements in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.